Back to search

Aristotle University Of Thessaloniki (AUTH)

Ανάπτυξη, αξιολόγηση, in silico μελέτες αναστολέων λιποξυγονάσης/τυροσινάσης για πιθανή τοπική θεραπεία δερματικών παθήσεων

Abstract

dc:description

The skin is considered the largest organ in the human body, so skin diseases pose a challenge to the scientific community. Inflammatory skin diseases such as psoriasis affect a large part of the global population. Although the condition is not life-threatening, it burdens the patient's daily life. Often, chronic skin inflammation leads to changes in skin color, specifically hyperpigmentation. Taking these skin abnormalities as our starting point, we focused our study on the action of two enzymes and their involvement in the pathophysiology of these conditions. These are lipoxygenases, a family of metalloenzymes that play an important role in the onset and intensification of inflammation. These are iron-containing enzymes that control the oxidation of polyunsaturated fatty acids such as arachidonic acid, thereby initiating the production of inflammatory mediators. The second enzyme studied is tyrosinase, a copper-containing metalloenzymes that is responsible for the production of melanin in the skin. It therefore plays a key role in skin hyperpigmentation. However, what prompted us to study these two enzymes simultaneously is the connection between them. More specifically, after years of skin inflammation, the oxidation products of arachidonic acid and their metabolites induce melanin production in melanocytes through the activation of tyrosinase. This phenomenon is called post-inflammatory hyperpigmentation. The aim of our study was to find compounds that act multifunctionally and can target both enzymes simultaneously. At the same time, we sought to find a more effective method of topical administration for the treatment of psoriasis and hyperpigmentation. We therefore selected three thiosemicarbazones with proven inhibitory activity from in vitro studies on the enzymes mentioned above. Our goal was to incorporate them into the innovative drug formulation we developed. This is a polymeric membrane produced by electrospinning, a process in which the polymer solution is converted into nanofibers under the influence of an electrostatic field. The nanofibers ensure a more controlled and uniform release of the active substance, and the application of these membranes is faster and easier than existing topical therapeutic approaches. The polymers we used were Poloxamer 407 and PVP K90 in a 30/70 ratio and were selected based on their biocompatibility and the morphology of the fibers they produce. After the membrane was developed, physicochemical tests were carried out on both pure polymer membranes and those containing the active substance in order to identify possible interactions between materials and the form in which the compound is found when incorporated into the polymers. The results we obtained were considered satisfactory.In the continuation of our study, we examined a series of tyrosinase inhibitors with proven in vitro inhibitory activity from the literature (Zolghadri et al, 2019) in order to develop their in silico profile. Also, using QSAR structure-activity relationships, we examined their ability to inhibit lipoxygenase, i.e. to act as multifunctional molecules. We used several in silico programs to obtain more reliable and repeatable results. The programs are as follows: Molinspiration, Molsoft, MedChem, SwissAdme and Preadmet, and the categories of compounds examined are Coumarin Derivatives, Chalcone Derivatives, Resveratrol Analogues, Piperidine Derivatives, Thiosemicarbazone Derivatives, Thiourea Derivatives, Thiazolidine Derivatives, Kojic Acid Analogues, and Benzaldehyde Derivatives. The in silico profile was developed for all compounds presented in the literature (Zolghadri et al, 2019), but we chose to present only the most potent ones based on IC50 on tyrosinase in our study. Emphasizing on predictions for drug-likeness and the ability to be administered topically, we arrived at the most promising categories. These are coumarin derivatives, chalcone derivatives and resveratrol analogues. From these categories, we selected the most potent compounds from each structural subcategory and studied them in silico in order to find the optimal molecules. Their profile was compared with that of Zileuton, a reference molecule for the inhibitory action on lipoxygenase, and tranexamic acid, a reference molecule for the inhibitory action on tyrosinase. We then examined whether these molecules could inhibit lipoxygenase through a series of QSAR relationships-structure QSAR and concluded that Coumarin Derivative 16 and the modified product Chalcone 13 are expected to be the most potent LOX inhibitors. We conducted molecular modelling studies on these compounds and on some others that showed reduced activity from the QSAR relationships to verify the prediction and understand how the molecules interact with lipoxygenase. The aromatic system of Coumarin Derivatives 15 and 16, in combination with the hydroxyl groups, ensures strong binding near the active site of the enzyme. However, the prediction that they are not able to cross the skin barrier from all predictive models is problematic. As for the Resveratrol Analogues, all molecules are expected to cross the blood-brain barrier, suggesting that they may cause neurological side effects and, at the same time, Molsoft does not predict that they will have a therapeutic effect, i.e. act as drugs. After comparing the results from all compounds, we conclude that the most promising molecule is the modified chalcone product, compound 13. This is a pleiotropic molecule that targets both enzymes, lipoxygenase and tyrosinase. It is predicted to be capable of providing a therapeutic effect according to drug-likeness studies and has a satisfactory profile in relation to dermal administration. More specifically, according to Molsoft, it is more likely to act as a drug than tranexamic acid. It is also important to note that the Brenk and Pains predictions do not identify any problems with its structure. It could therefore be an excellent candidate for a new compound for the treatment of psoriasis and skin hyperpigmentation, and it would be worthwhile to continue studying it in subsequent stages.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2025

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Katsali, Christiana
  • Κατσαλή, Χριστιάνα

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/59999

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Katsali, Christiana; Κατσαλή, Χριστιάνα. Ανάπτυξη, αξιολόγηση, in silico μελέτες αναστολέων λιποξυγονάσης/τυροσινάσης για πιθανή τοπική θεραπεία δερματικών παθήσεων. Aristotle University Of Thessaloniki (AUTH), 2025. http://hdl.handle.net/10442/hedi/59999